This consent order formalizes the procedural adjustments in the ongoing litigation between Health Bay Investment in Healthcare Enterprises & Development LLC, Anglo Arabian Healthcare Investments LLC, and Dr. Kamal Akkach, specifically addressing the extension of witness statement deadlines and the vacation of the previously scheduled trial window.
What specific procedural deadlines were adjusted for Health Bay Investment in Healthcare Enterprises & Development LLC and Dr. Kamal Akkach in the October 2021 consent order?
The litigation, registered under CFI 087/2019, involves complex disputes between the Claimants—Health Bay Investment in Healthcare Enterprises & Development LLC and Anglo Arabian Healthcare Investments LLC—and the Defendant, Dr. Kamal Akkach. The October 4, 2021, order serves as a critical procedural milestone, reflecting the parties' mutual agreement to recalibrate the timeline for evidence production and trial preparation. The primary adjustment concerned the exchange of witness statements of fact and any necessary hearsay notices, which were extended to 3:00 PM on October 10, 2021.
Furthermore, the order addressed the necessity of vacating the Pre-Trial Review that had been previously set for November 1, 2021. The court’s intervention here was purely administrative, facilitating the parties' request to move away from the original timeline established in the May Consent Order. As noted in the order:
Paragraph 8 of the May Consent Order is amended such that the Pre-Trial Review listed for 1 November 2021 be vacated.
This adjustment ensures that the parties have sufficient time to finalize their evidentiary submissions before the court reconvenes for pre-trial management.
Which DIFC Court official presided over the issuance of the CFI 087/2019 consent order on 4 October 2021?
The consent order was issued by Registrar Nour Hineidi of the DIFC Court of First Instance. The order was formally entered into the court record at 9:00 AM on October 4, 2021. Registrar Hineidi’s role in this matter reflects the standard practice within the DIFC Courts where the Registry oversees the management of complex civil litigation, ensuring that consent-based amendments to case management orders are properly documented and enforceable.
What were the respective positions of the Claimants and Dr. Kamal Akkach regarding the rescheduling of the trial in CFI 087/2019?
While the specific underlying legal arguments regarding the merits of the healthcare-sector dispute remain confidential, the parties reached a consensus regarding the logistical management of the trial. Both the Claimants (Health Bay Investment in Healthcare Enterprises & Development LLC and Anglo Arabian Healthcare Investments LLC) and the Defendant (Dr. Kamal Akkach) agreed that the trial, which was originally slated to commence on December 12, 2021, was no longer viable under the existing schedule.
By seeking this consent order, the parties effectively signaled to the court that additional time was required for the preparation of witness evidence and the coordination of trial logistics. The parties jointly requested that the trial be vacated and re-listed for a duration of three to five days, with the new commencement date to be set no earlier than March 1, 2022. This collaborative approach allowed the court to bypass a contested hearing on adjournment, instead issuing the order based on the mutual agreement of the parties.
What was the precise doctrinal issue the court addressed regarding the amendment of the May Consent Order in CFI 087/2019?
The court was tasked with the procedural question of whether to grant an amendment to an existing Case Management Order (CMO) based on the consent of all parties. The doctrinal issue centers on the court’s inherent power to manage its own docket and the flexibility afforded to parties under the Rules of the DIFC Courts (RDC) to adjust timelines for trial preparation.
The court had to determine if the proposed extensions and the vacation of the trial date were consistent with the overriding objective of the RDC, which emphasizes the efficient and cost-effective resolution of disputes. By formalizing the agreement, the court ensured that the procedural integrity of the case was maintained while accommodating the practical realities of the parties' litigation readiness. The court did not need to adjudicate on the merits of the dispute, but rather acted as the arbiter of the procedural timeline to ensure that the eventual trial would be conducted in a fair and orderly manner.
How did the court apply the principle of party autonomy in rescheduling the trial for Dr. Kamal Akkach?
The court’s reasoning was rooted in the principle of party autonomy, which allows litigants to define the pace of their own proceedings provided it does not unduly prejudice the court’s resources or the administration of justice. By acknowledging the agreement between the Claimants and the Defendant, the court exercised its discretion to vacate the December 2021 trial date and push the matter into the 2022 calendar.
The court’s reasoning process involved a systematic review of the previous procedural history, including the Agreed Case Management Order (ACM) from September 2020 and the subsequent series of consent orders issued throughout 2021. The court concluded that the parties were in the best position to assess their readiness for trial. Consequently, the court directed the parties to take an active role in fixing the new dates:
The parties shall correspond with the Court forthwith to provide their dates to avoid and fix the Pre-Trial Review hearing. 3. The parties shall correspond with the Court forthwith to provide their dates to avoid and fix the trial listing. 4.
This approach ensures that the new trial window is mutually convenient, thereby reducing the likelihood of future applications for further adjournments.
Which specific Rules of the DIFC Courts and previous orders were referenced in the 4 October 2021 consent order?
The order explicitly references the "Agreed Case Management Order" (ACM Order) dated September 21, 2020, as the foundational document for the case timeline. Furthermore, the court acknowledged a long history of procedural adjustments, citing the Consent Orders dated December 6, 2020, December 15, 2020, January 11, 2021, January 28, 2021, February 11, 2021, February 23, 2021, May 30, 2021 (the "May Consent Order"), July 1, 2021, and August 22, 2021 (the "August Consent Order").
The court also took into account the directions provided by the DIFC Courts’ Registry via email on April 20, 2021. By incorporating these references, the order maintains a clear chain of custody for the procedural rules governing the case, ensuring that all parties are bound by the most recent iteration of the case management schedule.
How did the court utilize the "May Consent Order" and "August Consent Order" in the context of the current proceedings?
The court utilized the May and August Consent Orders as the primary reference points for the amendments. Specifically, the court treated the May Consent Order as the governing document for the Pre-Trial Review and the trial listing, while the August Consent Order was used as the reference for the witness statement exchange deadlines.
By amending these specific paragraphs rather than issuing a new, standalone CMO, the court preserved the continuity of the litigation. This method of "amending by reference" is a standard practice in the DIFC Courts, which allows the parties to track the evolution of the case timeline without losing sight of the original obligations set out in the ACM Order.
What was the final disposition of the court regarding the trial schedule and costs in CFI 087/2019?
The court granted the order by consent, effectively vacating the trial date of December 12, 2021, and ordering that the trial be re-listed for a period of three to five days to commence no earlier than March 1, 2022. Additionally, the court ordered that the costs of the application be "costs in the case," meaning that the party ultimately successful in the litigation will likely be entitled to recover the costs associated with this specific procedural application.
What are the wider implications for practitioners managing complex healthcare litigation in the DIFC?
This case highlights the importance of maintaining a rigorous and documented procedural history in complex, multi-party litigation. For practitioners, the case demonstrates that the DIFC Courts are willing to accommodate reasonable requests for trial rescheduling, provided that the parties act in concert and maintain clear communication with the Registry.
Practitioners must anticipate that as a case progresses, the initial Case Management Order may require multiple amendments. The practice of using "consent orders" to manage these changes is an efficient way to keep the court informed and to ensure that all parties remain aligned on the timeline. Future litigants should note that the court expects parties to be proactive in providing "dates to avoid" to the Registry to prevent administrative delays when rescheduling significant events like Pre-Trial Reviews or trials.
Where can I read the full judgment in Health Bay Investment In Healthcare Enterprises & Development LLC v Dr. Kamal Akkach [2021] DIFC CFI 087?
The full text of the consent order can be accessed via the official DIFC Courts website: https://www.difccourts.ae/rules-decisions/judgments-orders/court-first-instance/cfi-087-2019-1-health-bay-investment-healthcare-enterprises-development-llc-2-anglo-arabian-healthcare-investments-llc-v-dr-kama-1 or via the CDN link: https://littdb.sfo2.cdn.digitaloceanspaces.com/litt/AE/DIFC/judgments/court-first-instance/DIFC_CFI-087-2019_20211004.txt.
Cases referred to in this judgment:
| Case | Citation | How used |
|---|---|---|
| N/A | N/A | No specific case law precedents were cited in this procedural consent order. |
Legislation referenced:
- Rules of the DIFC Courts (RDC)
- Judicial Authority Law (as applicable to the DIFC Court of First Instance)